glp-1 therapies success rate Receptor Agonist Market Growth Analysis GLP-1 Agonists Weight Loss Drugs

Research, including meta-analyses of randomized controlled trials, indicates these medications can achieve an average weight reduction of approximately 3 to 5% of initial body weight after 6 to 12 months of treatment

There are ways to pay less, such as the direct-to-consumer cash pay options offered by the manufacturers, Lilly Direct and Novo Care

Previously, meds in this class were just FDA-approved for type 2 diabetes

If not, Quinones says adjusting habits, like managing portion sizes, can help

Healthcare providers can assess whether symptoms represent medication adverse effects, complications of treatment, or unrelated medical conditions requiring specific intervention

doi:10.1111/jocd.15869